|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2608792 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11752700.2 |
| Date of filing the European patent application | 2011-08-24 | |
| (97) | Date of publication of the European application | 2013-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-11 |
| (46) | Date of publication of the claims translation | 2018-01-10 |
| (86) | Number | PCT/US2011/048922 |
| Date | 2011-08-24 |
| (87) | Number | WO 2012/027445 |
| Date | 2012-03-01 |
| (30) | Number | Date | Country code |
| 377177 P | 2010-08-26 | US |
| (72) |
LORENCE, Robert Michael, US
SHAHIDI, Mehdi, GB
STOPFER, Peter, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | EGFR inhibitoriaus vartojimo būdai |
| METHODS OF ADMINISTERING AN EGFR INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2023-07-21 | 13 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-06-03 |